Cargando…
Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
Weight loss due to skeletal muscle atrophy in patients with chronic pulmonary disease is negatively correlated with clinical outcome. Pulmonary fibrosis is a chronic and progressive interstitial lung disease characterized by the dysregulated deposition of the extracellular matrix (ECM) with the dest...
Autores principales: | Shieh, Jiunn-Min, Tseng, Hui-Yun, Jung, Fang, Yang, Shih-Hsing, Lin, Jau-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458868/ https://www.ncbi.nlm.nih.gov/pubmed/31049028 http://dx.doi.org/10.1155/2019/7947596 |
Ejemplares similares
-
Membrane Translocation of IL-33 Receptor in Ventilator Induced Lung Injury
por: Yang, Shih-Hsing, et al.
Publicado: (2015) -
The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin
por: Fanny, Manoussa, et al.
Publicado: (2018) -
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
por: Wilson, Mark S., et al.
Publicado: (2010) -
IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease
por: Versace, Antonio Giovanni, et al.
Publicado: (2022) -
IL-33 Depletion in COVID-19 Lungs
por: Gaurav, Rohit, et al.
Publicado: (2021)